Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,043 | 36,211 | 19,131 | 19,174 | 32,141 |
| Marketable Securities | 5,349 | 3,012 | N/A | 7,080 | 665 |
| Receivables | 2,300 | 1,298 | 1,969 | N/A | 2,089 |
| Inventories | N/A | N/A | N/A | N/A | 2,142 |
| Other current assets | 6,790 | 6,954 | 7,918 | 10,027 | 4,376 |
| TOTAL | $38,482 | $47,475 | $29,018 | $36,282 | $41,414 |
| Non-Current Assets | |||||
| PPE Net | 17,095 | 16,812 | 15,852 | 15,961 | 15,687 |
| Intangibles | 62,916 | 63,067 | 72,618 | 72,770 | 72,921 |
| Other Non-Current Assets | 1,210 | 1,272 | 1,325 | 1,264 | 1,317 |
| TOTAL | $81,221 | $81,150 | $89,796 | $89,994 | $89,925 |
| Total Assets | $119,703 | $128,625 | $118,814 | $126,275 | $131,339 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,361 | 2,243 | 1,110 | N/A |
| Accounts payable and accrued liabilities | 2,467 | 2,266 | 2,929 | 5,661 | 4,400 |
| Accrued Expenses | 8,011 | 7,178 | 5,724 | 4,323 | 2,819 |
| Other current liabilities | 5,498 | 4,643 | 5,506 | 4,334 | 3,640 |
| TOTAL | $19,740 | $16,331 | $17,463 | $16,245 | $11,855 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,063 | 14,894 | 12,757 | 14,716 | 15,000 |
| Other Non-Current Liabilities | 17,354 | 16,959 | 20,447 | 19,143 | 24,205 |
| TOTAL | $44,966 | $46,340 | $51,383 | $51,957 | $57,425 |
| Total Liabilities | $64,706 | $62,671 | $68,845 | $68,202 | $69,280 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 369 | 369 | 268 | 257 | 238 |
| Common Shares | 56 | 56 | 39 | 37 | 36 |
| Retained earnings | -338,936 | -327,560 | -310,433 | -291,247 | -279,635 |
| Other shareholders' equity | -138 | -132 | -141 | -145 | -650 |
| TOTAL | $54,996 | $65,953 | $49,969 | $58,074 | $62,059 |
| Total Liabilities And Equity | $119,703 | $128,625 | $118,814 | $126,275 | $131,339 |